SkyePharma finally gets EU nod for Flutiform
This article was originally published in Scrip
Executive Summary
SkyePharma has finally secured European approval of its asthma treatment Flutiform under the decentralised procedure. The decision follows a nod from the European Medicines Agency advisory committee, the CHMP, earlier this year (scripintelligence.com, 24 April 2012).